{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,17]],"date-time":"2026-11-17T17:41:15Z","timestamp":1794937275993,"version":"4.9.1"},"reference-count":63,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"5","license":[{"start":{"date-parts":[[2024,1,18]],"date-time":"2024-01-18T00:00:00Z","timestamp":1705536000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/ http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"abstract":"<jats:sec>\n            <jats:title>Introduction:<\/jats:title>\n            <jats:p>Gut microbiota has emerged as a pivotal player in cardiovascular health and disease, extending its influence beyond the gut through intricate metabolic processes and interactions with the immune system. Accumulating evidence supports a significant association between gut microbiota and cardiovascular diseases such as atherosclerosis, hypertension, and heart failure. Dietary patterns have been identified as key factors shaping the composition of the gut microbiota and exerting notable impacts on cardiovascular health. Probiotics and prebiotics have shown promise in mitigating the risks of cardiovascular disease by modulating key cardiovascular parameters. Faecal microbiota transplantation (FMT) has recently emerged as a novel and intriguing therapeutic strategy.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Aim:<\/jats:title>\n            <jats:p>This review paper aims to explore and elucidate the multifaceted role of gut microbiota in cardiovascular health. It will also address the prevailing challenges and limitations in gut microbiota studies, emphasizing the importance of future research in overcoming these obstacles to expand our understanding of the gut-heart axis.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Materials and methods:<\/jats:title>\n            <jats:p>A comprehensive literature search was conducted using various databases including ClinicalTrials, Google Scholar, PubMed, ScienceDirect, MEDLINE, and Ovid Resources. The search strategy included utilizing keywords such as \u201cGut microbiota,\u201d \u201cRandomized controlled trials (RCTs),\u201d \u201cGut-heart axis,\u201d \u201cDysbiosis,\u201d \u201cDiet,\u201d \u201cProbiotics,\u201d \u201cPrebiotics,\u201d \u201cFaecal Microbiota transplantation,\u201d \u201ccardiovascular disease,\u201d \u201cMeta-analyses,\u201d and other compatible terms thereof. Only articles written in English were considered, and selection criteria included relevance to the research objectives, reasonable sample sizes, and robust methodology. In addition to the identified articles, meta-analyses, animal models and studies, and references from the selected articles were also examined to ensure a comprehensive review of the literature.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>Dietary patterns exert a significant influence on the composition of the gut microbiota, and certain diets, such as the Mediterranean diet, have been associated with a favourable gut microbiota profile and a reduced risk of cardiovascular disease (CVD). Probiotics and prebiotics have emerged as potential interventions to mitigate CVD risks by modulating blood pressure, glycemic control, lipid profiles, and gut dysbiosis. Another innovative therapeutic approach is FMT, which involves transferring faecal material from a healthy donor to restore a balanced gut microbiota. FMT holds promise for improving cardiometabolic parameters in individuals with CVD, although further research is needed to elucidate its precise mechanisms and assess its effectiveness.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>The gut microbiota is emerging as a potential therapeutic target for CVD prevention and management. However, current research has limitations, including the need for larger and more diverse studies, the challenges of establishing causality, and concerns regarding the long-term consequences and safety of gut microbiota modulation. Despite these limitations, understanding the gut-heart axis holds promise for the development of personalized therapies and interventions for cardiovascular health. Further research is needed to expand our knowledge and address the ethical and safety issues associated with gut microbiota modification.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/ms9.0000000000001744","type":"journal-article","created":{"date-parts":[[2024,1,17]],"date-time":"2024-01-17T07:00:34Z","timestamp":1705474834000},"page":"2752-2758","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":55,"title":["Unlocking the gut-heart axis: exploring the role of gut microbiota in cardiovascular health and disease"],"prefix":"10.1097","volume":"86","author":[{"given":"Sanobar","family":"Shariff","sequence":"first","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Yerevan State Medical University, Yerevan, Armenia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia","family":"Kwan Su Huey","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Medical School, University of Glasgow, Glasgow, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishant","family":"Parag Soni","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"GMERS Medical College, Ahmedabad, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amer","family":"Yahia","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Mohamed 6 of Health Sciences, Casablanca, Morocco"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doha","family":"Hammoud","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"National University of Pharmacy, Kharkiv, Ukraine"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abubakar","family":"Nazir","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Department of Medicine, King Edward Medical University, Lahore, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Uwishema","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"Clinton Global Initiative University, New York, NY"},{"name":"Faculty of Medicine, Karadeniz Technical University, Trabzon, Turkey"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magda","family":"Wojtara","sequence":"additional","affiliation":[{"name":"Oli Health Magazine Organization, Research and Education, Kigali, Rwanda"},{"name":"University of Michigan Medical School; Ann Arbor, MI"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2024,5]]},"reference":[{"key":"R1-20250806","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/nature18846","article-title":"Diet\u2013microbiota interactions as moderators of human metabolism","volume":"535","author":"Sonnenburg","year":"2016","journal-title":"Nature"},{"key":"R2-20250806","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1016\/j.jacc.2019.10.009","article-title":"The global burden of cardiovascular diseases and risk factors: 2020 and beyond","volume":"74","author":"Mensah","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"R3-20250806","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/eurheartj\/ehz859","article-title":"European Society of Cardiology: Cardiovascular Disease Statistics 2019","volume":"41","author":"Timmis","year":"2020","journal-title":"Eur Heart J"},{"key":"R4-20250806","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1038\/nrmicro.2017.149","article-title":"Microbial modulation of cardiovascular disease","volume":"16","author":"Brown","year":"2018","journal-title":"Nat Rev Genet"},{"key":"R5-20250806","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1007\/s13238-020-00785-9","article-title":"Gut microbes in cardiovascular diseases and their potential therapeutic applications","volume":"12","author":"Jin","year":"2020","journal-title":"Protein Cell"},{"key":"R6-20250806","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics-2016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"R7-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2020\/1974265","article-title":"Implication of gut microbiota in cardiovascular diseases","volume":"2020","author":"Zhou","year":"2020","journal-title":"Oxidat Med Cell Longevity"},{"key":"R8-20250806","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1038\/nature08821","article-title":"A human gut microbial gene catalogue established by metagenomic sequencing","volume":"464","author":"Qin","year":"2010","journal-title":"Nature"},{"key":"R9-20250806","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1126\/science.1110591","article-title":"Diversity of the human intestinal microbial flora","volume":"308","author":"Eckburg","year":"2005","journal-title":"Science"},{"key":"R10-20250806","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1126\/science.1124234","article-title":"Metagenomic analysis of the human distal gut microbiome","volume":"312","author":"Gill","year":"2006","journal-title":"Science"},{"key":"R11-20250806","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nm.3145","article-title":"Intestinal microbiota metabolism of L-carnitine, a nutrient in red meat, promotes atherosclerosis","volume":"19","author":"Koeth","year":"2013","journal-title":"Nat Med"},{"key":"R12-20250806","doi-asserted-by":"crossref","first-page":"e003698","DOI":"10.1161\/JAHA.116.003698","article-title":"Gut microbiota promote angiotensin II\u2013induced arterial hypertension and vascular dysfunction","volume":"5","author":"Karbach","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"R13-20250806","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1161\/HYPERTENSIONAHA.115.05315","article-title":"Gut dysbiosis is linked to hypertension","volume":"65","author":"Yang","year":"2015","journal-title":"Hypertension"},{"key":"R14-20250806","article-title":"Gut microbiota and microbial metabolism in early risk of cardiometabolic disease","author":"Curtis","year":"2023","journal-title":"AHA J"},{"key":"R15-20250806","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.3390\/foods11182863","article-title":"Health benefits and side effects of short-chain fatty acids","volume":"11","author":"Xiong","year":"2022","journal-title":"Foods"},{"key":"R16-20250806","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.3390\/nu11051026","article-title":"Effects of intestinal microbial\u207belaborated butyrate on oncogenic signaling pathways","volume":"11","author":"Chen","year":"2019","journal-title":"Nutrients"},{"key":"R17-20250806","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1136\/gutjnl-2019-319654","article-title":"Mediterranean diet intervention alters the gut microbiome in older people reducing frailty and improving health status: the NU-AGE 1-year dietary intervention across five European countries","volume":"69","author":"Ghosh","year":"2020","journal-title":"Gut"},{"key":"R19-20250806","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/ajcn\/nqx082","article-title":"Dietary fiber and health outcomes: An umbrella review of systematic reviews and meta-analyses","volume":"107","author":"Veronese","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"R20-20250806","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.3390\/nu13041162","article-title":"Gut dysbiosis and western diet in the pathogenesis of essential arterial hypertension: a narrative review","volume":"13","author":"Canale","year":"2021","journal-title":"Nutrients"},{"key":"R21-20250806","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40168-016-0222-x","article-title":"Gut microbiota dysbiosis contributes to the development of hypertension","volume":"5","author":"Li","year":"2017","journal-title":"Microbiome"},{"key":"R25-20250806","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1038\/s41467-017-00900-1","article-title":"The gut microbiome in atherosclerotic cardiovascular disease","volume":"8","author":"Jie","year":"2017","journal-title":"Nat Commun"},{"key":"R27-20250806","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"R28-20250806","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.1016\/j.clnu.2018.06.1118","article-title":"Evaluation of the effect of lactobacillus Reuteri V3401 on biomarkers of inflammation and cardiovascular risk in obese adults with metabolic syndrome: a randomized clinical trial (PROSIR)","volume":"37","author":"Tenorio-Jim\u00e9nez","year":"2018","journal-title":"Clin Nutr"},{"key":"R30-20250806","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/j.medcli.2018.09.007","article-title":"Effect of probiotics on lipid profiles in hypercholesterolaemic adults: a meta-analysis of randomized controlled trials","volume":"152","author":"Mo","year":"2019","journal-title":"Med Cl\u00edn"},{"key":"R32-20250806","first-page":"e13199","article-title":"Effects of probiotics on body weight, body mass index, fat mass and fat percentage in subjects with overweight or obesity: a systematic review and meta-analysis of randomized controlled trials","volume":"22","author":"Borgeraas","year":"2021","journal-title":"Obes Rev"},{"key":"R33-20250806","first-page":"1479","article-title":"Potential benefits of garlic and other dietary supplements for the management of hypertension (Review)","volume":"19","author":"Matsutomo","year":"2019","journal-title":"Exp Ther Med"},{"key":"R34-20250806","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1007\/s40200-020-00525-0","article-title":"Effect of probiotic foods and supplements on blood pressure: a systematic review of meta-analyses studies of controlled trials","volume":"19","author":"Ejtahed","year":"2020","journal-title":"J Diabetes Metab Disord"},{"key":"R37-20250806","doi-asserted-by":"crossref","first-page":"3972","DOI":"10.1038\/s41598-021-83252-7","article-title":"Lactobacillus Plantarum 299v probiotic supplementation in men with stable coronary artery disease suppresses systemic inflammation","volume":"11","author":"Hofeld","year":"2021","journal-title":"Sci Rep"},{"key":"R38-20250806","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1186\/s12937-021-00703-7","article-title":"Effect of probiotic supplementation along with calorie restriction on metabolic endotoxemia and inflammation markers in coronary artery disease patients: a double-blind placebo-controlled randomized clinical trial","volume":"20","author":"Moludi","year":"2021","journal-title":"Nutr J"},{"key":"R40-20250806","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tifs.2019.09.004","article-title":"Prebiotics: trends in food, health and technological applications","volume":"93","author":"Farias","year":"2019","journal-title":"Trends Food Sci Technol"},{"key":"R41-20250806","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/B978-0-12-800100-4.00003-9","article-title":"The role of short-chain fatty acids in health and disease","volume":"121","author":"Tan","year":"2014","journal-title":"Adv Immunol"},{"key":"R42-20250806","first-page":"1","article-title":"The effects of co-administration of probiotics and prebiotics on chronic inflammation and depression symptoms in patients with coronary artery diseases: a randomized clinical trial","volume":"10","author":"Moludi","year":"2021","journal-title":"Nutr Neurosci"},{"key":"R45-20250806","doi-asserted-by":"crossref","first-page":"216","DOI":"10.7570\/jomes.2019.28.4.216","article-title":"Effect of diet on the gut microbiota associated with obesity","volume":"28","author":"Kim","year":"2019","journal-title":"J Obesity Metab Synd"},{"key":"R46-20250806","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2017.05.055","article-title":"Prebiotics reduce body fat and alter intestinal microbiota in children who are overweight or with obesity","volume":"153","author":"Nicolucci","year":"2017","journal-title":"Gastroenterology"},{"key":"R48-20250806","doi-asserted-by":"crossref","first-page":"2","DOI":"10.3389\/fcimb.2019.00002","article-title":"The super-donor phenomenon in fecal microbiota transplantation","volume":"9","author":"Wilson","year":"2019","journal-title":"Front Cell Infect Microbiol"},{"key":"R49-20250806","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.mib.2018.07.003","article-title":"Low diversity gut microbiota dysbiosis: drivers, functional implications and recovery","volume":"44","author":"Kriss","year":"2018","journal-title":"Curr Opin Microbiol"},{"key":"R50-20250806","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.cmet.2017.09.008","article-title":"Improvement of insulin sensitivity after lean donor feces in metabolic syndrome is driven by baseline intestinal microbiota composition","volume":"26","author":"Kootte","year":"2017","journal-title":"Cell Metab"},{"key":"R51-20250806","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1053\/j.gastro.2012.06.031","article-title":"Transfer of intestinal microbiota from lean donors increases insulin sensitivity in individuals with metabolic syndrome","volume":"143","author":"Vrieze","year":"2012","journal-title":"Gastroenterology"},{"key":"R53-20250806","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1136\/gutjnl-2020-323617","article-title":"Microbiota engraftment after faecal microbiota transplantation in obese subjects with type 2 diabetes: a 24-week, double-blind, randomised controlled trial","volume":"71","author":"Ng","year":"2022","journal-title":"Gut"},{"key":"R54-20250806","article-title":"Streptococcus species abundance in the gut is linked to subclinical coronary atherosclerosis in 8973 participants from the SCAPIS cohort [Internet]","author":"Sayols-Baixeras","year":"2023","journal-title":"AHA journal"},{"key":"R55-20250806","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1038\/nrcardio.2017.169","article-title":"Association between the gut microbiome and atherosclerosis","volume":"14","author":"Barrington","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"R56-20250806","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1111\/apm.13038","article-title":"Gut microbiota in atherosclerosis: focus on trimethylamine N\u2010oxide","volume":"128","author":"Zhu","year":"2020","journal-title":"APMIS"},{"key":"R57-20250806","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3390\/nu13010144","article-title":"Role of gut microbiota and their metabolites on atherosclerosis, hypertension, and human blood platelet function: a review","volume":"13","author":"Duttaroy","year":"2021","journal-title":"Nutrients"},{"issue":"suppl_1","key":"R58-20250806","doi-asserted-by":"crossref","first-page":"4592","DOI":"10.1073\/pnas.1011383107","article-title":"Human oral, gut, and plaque microbiota in patients with atherosclerosis","volume":"108","author":"Koren","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"R59-20250806","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.lfs.2018.10.063","article-title":"Interaction between gut microbiome and cardiovascular disease","volume":"214","author":"Peng","year":"2018","journal-title":"Life Sci"},{"key":"R60-20250806","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1042\/CS20171090","article-title":"Gut microbiota in cardiovascular disease and heart failure","volume":"132","author":"Kitai","year":"2018","journal-title":"Clin Sci"},{"key":"R61-20250806","article-title":"Gut microbiota and cardiovascular diseases axis","volume":"113","author":"Moldovan","year":"2022","journal-title":"Minerva Med [Internet]"},{"key":"R62-20250806","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.clinre.2017.09.006","article-title":"Gut microbiota and hypertension: From pathogenesis to new therapeutic strategies","volume":"42","author":"Kang","year":"2018","journal-title":"Clin Res Hepatol Gastroenterol"},{"key":"R63-20250806","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.3390\/ijerph18031248","article-title":"Targeting gut microbiota to treat hypertension: a systematic review","volume":"18","author":"Palmu","year":"2021","journal-title":"IJERPH"},{"key":"R64-20250806","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MNH.0000000000000293","article-title":"The gut microbiome and hypertension","volume":"26","author":"Pevsner-Fischer","year":"2017","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"R65-20250806","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1161\/CIRCRESAHA.118.314642","article-title":"Gut microbial associations to plasma metabolites linked to cardiovascular phenotypes and risk: a cross-sectional study","volume":"124","author":"Kurilshikov","year":"2019","journal-title":"Circ Res"},{"key":"R66-20250806","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1177\/1756283X16637819","article-title":"Novel perspectives on therapeutic modulation of the gut microbiota","volume":"9","author":"McCarville","year":"2016","journal-title":"Therap Adv Gastroenterol"},{"key":"R67-20250806","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.3390\/microorganisms9071469","article-title":"Nutritional interventions targeting gut Microbiota during cancer therapies","volume":"9","author":"Rinninella","year":"2021","journal-title":"Microorganisms"},{"key":"R68-20250806","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.chom.2020.01.022","article-title":"Therapeutics targeting the gut microbiome: Rigorous pipelines for drug development","volume":"27","author":"Markey","year":"2020","journal-title":"Cell Host Microbe"},{"key":"R69-20250806","doi-asserted-by":"crossref","first-page":"663","DOI":"10.4070\/kcj.2017.0028","article-title":"Novel concept of a heart-gut axis in the pathophysiology of heart failure","volume":"47","author":"Kamo","year":"2017","journal-title":"Korean Circ J"},{"key":"R70-20250806","doi-asserted-by":"crossref","first-page":"e000993","DOI":"10.1136\/openhrt-2018-000993","article-title":"The heart-gut axis: new target for atherosclerosis and congestive heart failure therapy","volume":"6","author":"Forkosh","year":"2019","journal-title":"Open Heart"},{"key":"R71-20250806","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/nm.3196","article-title":"A gut-heart connection in cardiometabolic regulation","volume":"19","author":"Buglioni","year":"2013","journal-title":"Nat Med"},{"key":"R72-20250806","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.hfc.2019.08.001","article-title":"The gut axis involvement in heart failure: Focus on Trimethylamine N-oxide","volume":"16","author":"Salzano","year":"2020","journal-title":"Heart Fail Clin"},{"key":"R73-20250806","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.cell.2016.02.011","article-title":"Gut microbial metabolite TMAO enhances platelet hyperreactivity and thrombosis risk","volume":"165","author":"Zhu","year":"2016","journal-title":"Cell"},{"key":"R74-20250806","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1056\/NEJMra1600266","article-title":"The human intestinal microbiome in health and disease","volume":"375","author":"Lynch","year":"2016","journal-title":"N Engl J Med"},{"key":"R75-20250806","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1126\/science.aad3503","article-title":"Population-level analysis of gut microbiome variation","volume":"352","author":"Falony","year":"2016","journal-title":"Science"},{"key":"R76-20250806","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1109400","article-title":"Intestinal microbial metabolism of phosphatidylcholine and cardiovascular risk","volume":"368","author":"Tang","year":"2013","journal-title":"N Engl J Med"},{"key":"R77-20250806","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1126\/science.1224396","article-title":"Is it time for a metagenomic basis of therapeutics?","volume":"336","author":"Haiser","year":"2012","journal-title":"Science"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001744","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,8,6]],"date-time":"2025-08-06T13:24:51Z","timestamp":1754486691000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/MS9.0000000000001744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,1,18]]},"references-count":63,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000001744","relation":{},"ISSN":["2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,1,18]]},"assertion":[{"value":"2023-09-23","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2023-12-24","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}